Axiom Therapeutics key facts
- Developer of an advanced computational platform intended to treat undruggable diseases.
- It has raised $2.0M; the latest was Accelerator/Incubator in Sep 2025.
- Notable investors include Plug and Play Tech Center, Innovate UK, Transpose Platform Management, Gaingels, Entrepreneurs First — 15 tracked in total.
- Status: Privately Held (backing).
Who backs Axiom Therapeutics
15+- ·The complete investor list: 15 names
- ·Watch Axiom Therapeutics: the Monday email on marks, rounds and moves
Axiom Therapeutics funding rounds
No funding rounds for Axiom Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Axiom Therapeutics investors
15 investors are on record for Axiom Therapeutics, including Plug and Play Tech Center, Innovate UK, Transpose Platform Management and Gaingels. By type, the record holds 5 venture capital firms and 1 asset manager.
About Axiom Therapeutics
Developer of an advanced computational platform intended to treat undruggable diseases. The company offers a model that predicts covalent drug interactions with cancer-causing proteins, helping researchers in cancer treatment and accelerating research and treatment development.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2024
- Employees
- 8
- Website
- axiom-therapeutics.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Axiom Therapeutics doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.